# Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients

> **NCT04437823** · PHASE2 · COMPLETED · sponsor: **Jinnah Hospital** · enrollment: 5 (actual)

## Conditions studied

- Corona Virus Infection

## Interventions

- **BIOLOGICAL:** Intravenous Infusions of Stem Cells

## Key facts

- **NCT ID:** NCT04437823
- **Lead sponsor:** Jinnah Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-11-30
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04437823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04437823, "Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04437823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*